Altretamine | Ferroptosis inducer
NMR (Conforms)
Available Options
| Size: | Price | Quantity | |
|---|---|---|---|
| 20 mg | $35.00 | ||
| 100 mg | $100.00 |
Altretamine (645-05-6) induces ferroptosis by inhibiting glutathione peroxidase 4 (GPX4) which causes accumulation of lipid hydroperoxides.1 Ferroptosis induction may be its mechanism of action as a cancer chemotherapeutic.2 Clinically useful agent for ovarian cancer.3,4
References/Citations:
- Woo et al. (2015), Elucidating Compound Mechanism of Action by Network Perturbation Analysis; Cell, 162 441
- Ye et al. (2021), The mechanisms and therapeutic targets of ferroptosis in cancer; Expert Opin. Ther. Targets, 25 965
- Alberts et al. (2004), Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group; Int. J. Gynecol. Cancer, 14 224
- Chan et al. (2004), Oral altretamine used as salvage therapy in recurrent ovarian cancer; Gynecol. Oncol., 92 368
NMR (Conforms)
Safety Data Sheet:
Product Data Sheet:
Materials provided by Focus Biomolecules are for laboratory research use only and are not intended for human or veterinary applications. Please note that we do not sell to individuals and that all orders placed by non-research organizations will incur a $20 restocking/refund fee
Altretamine (645-05-6) induces ferroptosis by inhibiting glutathione peroxidase 4 (GPX4) which causes accumulation of lipid hydroperoxides.1 Ferroptosis induction may be its mechanism of action as a cancer chemotherapeutic.2 Clinically useful agent for ovarian cancer.3,4
References/Citations:
- Woo et al. (2015), Elucidating Compound Mechanism of Action by Network Perturbation Analysis; Cell, 162 441
- Ye et al. (2021), The mechanisms and therapeutic targets of ferroptosis in cancer; Expert Opin. Ther. Targets, 25 965
- Alberts et al. (2004), Long-term follow-up of a phase II trial of oral altretamine for consolidation of clinical complete remission in women with stage III epithelial ovarian cancer in the Southwest Oncology Group; Int. J. Gynecol. Cancer, 14 224
- Chan et al. (2004), Oral altretamine used as salvage therapy in recurrent ovarian cancer; Gynecol. Oncol., 92 368
Related products
-
MitoBloCK-12 | Mitochondrial import inhibitor
From $40.00CAS:522-51-0Catalog Number:10-1525Activity:Mitochondrial import inhibitorChemical Name:1,1’-Decamethylenebis(4-aminoquinaldinium)dichlorideAlternate Name:Dequalinium chloride; MB12; DECAMolecular Weight:527.58Molecular Formula:C30H40Cl2N4Solubility:Soluble in DMSO (up to 1 mg/ml with warming) or in Water (up to 1 mg/ml)Physical Properties:Beige solidPurity:98% by TLC
NMR (Conforms)Storage Temperature:RTStability:Stable for 2 years as supplied. Solutions in DMSO or distilled water may be stored at -20° for up to 3 months.Shipping Code:RT -
AZ3146 | Mps1 kinase inhibitor
From $60.00CAS:1124329-14-1Catalog Number:10-4778Activity:Mps1 kinase inhibitorChemical Name:9-Cyclopentyl-2-[2-methoxy-4-(1-methylpiperidine-4-yl)oxyanilino]-7-methylpurin-8-oneMolecular Weight:452.56Molecular Formula:C24H32N6O3S2Solubility:Soluble in DMSO (up to 10 mg/ml) or in Ethanol (up to at least 25 mg/ml)Physical Properties:Off-white solidPurity:98% by HPLC
NMR (Conforms)Storage Temperature:-20°Stability:Stable for 1 year as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 1 month.Shipping Code:RT
Calculate the molar concentration, mass or volume in a solution.
Concentration × Volume × Molecular Weight = Mass
